DEFINITIVE PROXY STATEMENT

Company

Mosaic ImmunoEngineering Inc.

Filed

December 8, 2009

Period of Report

January 28, 2010

Accession Number

0001019687-09-004450

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →